Glimepiride/pioglitazone

General description GRK3 or beta-adrenergic receptor kinase 2 specifically phosphorylates the agonist-occupied form of the beta-adrenergic and related G protein-coupled receptors. GRK3 is a member of the receptor kinase family that broadly serves

GRK5 (G protein-coupled receptor kinase 5) belongs to the G-protein coupled receptor kinase family, and shows major expression in normal human heart. This protein contains a nuclear localization sequence and hence localizes in nucleus.

A TLR7 agonist.

Biochem/physiol Actions GSK 4716 is an Estrogen-related receptors ERR&#946 and ERR&#947 agonist with minimal activity for ERR&#945, ER&#945 and ER&#946 Features and Benefits This compound is featured on the Nuclear Receptors (Steroids) page of

Biochem/physiol Actions GSK 4716 is an Estrogen-related receptors ERR&#946 and ERR&#947 agonist with minimal activity for ERR&#945, ER&#945 and ER&#946 Features and Benefits This compound is featured on the Nuclear Receptors (Steroids) page of

Alsterpaullone exhibits anticancer, anti-angiogenic, antiviral, and neuroprotective activities. Alsterpaullone inhibits cyclin-dependent kinases (CDKs), inducing G2/M phase cell cycle arrest and apoptosis in leukemia cells.

Alsterpaullone exhibits anticancer, anti-angiogenic, antiviral, and neuroprotective activities. Alsterpaullone inhibits cyclin-dependent kinases (CDKs), inducing G2/M phase cell cycle arrest and apoptosis in leukemia cells.

GSK3&beta Inhibitor II is a potent inhibitor of glycogen synthase kinase-3&beta (GSK3&beta IC₅₀ = 390 nM) that does not inhibit GSK-3&alpha. Also referred to as tip-oxadiazole, this compound blocks the functional regulation of p53 by

GSK3&beta Inhibitor II is a potent inhibitor of glycogen synthase kinase-3&beta (GSK3&beta IC₅₀ = 390 nM) that does not inhibit GSK-3&alpha. Also referred to as tip-oxadiazole, this compound blocks the functional regulation of p53 by

A PPAR&beta/&delta antagonist.

A PPAR&beta/&delta antagonist.

A PPAR&beta/&delta antagonist.